Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NCT07500116 · Stroke (CVA) or TIA, Stroke Recurrence
NCT07414732 · Stroke, Intracerebral Haemorrhage, and more
NCT06783049 · Ischemic Stroke, Transient Ischemic Attack (TIA)
NCT07319312 · Stroke Acute, Stroke (CVA) or Transient Ischemic Attack
NCT07143149 · Ischemic Stroke, Transient Ischemic Attack (TIA)
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions